收藏切换
The application and prospects of chimeric antigen receptor T cell therapy in pediatric diseases
收藏切换
Danqing HU1, Chan HUANG2, Yuwei LU3, Xinghao JIN4a, Zibin BU4b, Wei ZHOU4c, *
World Clinical Drug | 2026, 47(4) : 425 - 434
Less
收藏切换
World Clinical Drug | 2026, 47(4): 425-434
• Review •
The application and prospects of chimeric antigen receptor T cell therapy in pediatric diseases
Full
Danqing HU1, Chan HUANG2, Yuwei LU3, Xinghao JIN4a, Zibin BU4b, Wei ZHOU4c, *
Affiliations
  • 1.The Second Affiliated School of Zhejiang Chinese Medical University, Hangzhou 310053, Zhejiang Province, China
  • 2.Nanjing Medical University, Nanjing 211166, Jiangsu Province, China
  • 3.Graduate Training Base of Wenzhou Medical University, Wenzhou 325035, Zhejiang Province, China
  • 4a.Department of Rheumatology and Immunology,Children's Hospital of Zhejiang University, Hangzhou 310052, Zhejiang Province, China
  • 4b.Department of Hematology,Children's Hospital of Zhejiang University, Hangzhou 310052, Zhejiang Province, China
  • 4c.Department of Nephrology, Children's Hospital of Zhejiang University, Hangzhou 310052, Zhejiang Province, China
Published: 2026-04-10 doi: 10.13683/j.wph.2026.04.012
Outline
收藏切换

Chimeric antigen receptor T cell therapy(CAR-T cell therapy) is a revolutionary cell-based immunotherapy technique that has initiated innovative exploration and clinical practice in pediatric medicine, bringing therapeutic hope to children with refractory and severe diseases. However, it may be accompanied by adverse reactions, which remains a key issue to be focused on in current research and clinical application. This paper comprehensively reviewed the latest research progress of CAR-T cell therapy at home and abroad, systematically summarized the application status of this therapy in pediatric hematological malignancies, solid tumors, and autoimmune diseases, and conducted in-depth analysis of its mechanism, providing a reference for clinical practice.

chimeric antigen receptor T cell therapy  /  pediatric disease  /  tumorous disease  /  autoimmune disease
胡丹青, 黄婵, 陆雨薇, 金星昊, 卜梓斌, 周维. 嵌合抗原受体T细胞治疗在儿童疾病中的应用与展望. 世界临床药物, 2026 , 47 (4) : 425 -434 . DOI: 10.13683/j.wph.2026.04.012
Danqing HU, Chan HUANG, Yuwei LU, Xinghao JIN, Zibin BU, Wei ZHOU. The application and prospects of chimeric antigen receptor T cell therapy in pediatric diseases[J]. World Clinical Drug, 2026 , 47 (4) : 425 -434 . DOI: 10.13683/j.wph.2026.04.012
Year 2026 volume 47 Issue 4
57
13
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2026.04.012
  • Receive Date:2025-01-11
  • Online Date:2026-11-05
  • Published:2026-04-10
Article Data
Affiliations
History
  • Received:2025-01-11
  • Revised:2025-05-12
Affiliations
    1.The Second Affiliated School of Zhejiang Chinese Medical University, Hangzhou 310053, Zhejiang Province, China
    2.Nanjing Medical University, Nanjing 211166, Jiangsu Province, China
    3.Graduate Training Base of Wenzhou Medical University, Wenzhou 325035, Zhejiang Province, China
    4a.Department of Rheumatology and Immunology,Children's Hospital of Zhejiang University, Hangzhou 310052, Zhejiang Province, China
    4b.Department of Hematology,Children's Hospital of Zhejiang University, Hangzhou 310052, Zhejiang Province, China
    4c.Department of Nephrology, Children's Hospital of Zhejiang University, Hangzhou 310052, Zhejiang Province, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2026.04.012
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT